Literature DB >> 33622338

French recommendations for the management of Behçet's disease.

Isabelle Kone-Paut1, Stéphane Barete2, Bahram Bodaghi3, Kumaran Deiva4,5, Anne-Claire Desbois6,7,8, Caroline Galeotti9, Julien Gaudric10, Gilles Kaplanski11, Alfred Mahr12, Nicolas Noel13,14,15, Maryam Piram9,16, Tu-Anh Tran17, Bertrand Wechsler6,7,8, David Saadoun18,19,20.   

Abstract

Behçet's disease (BD) is a systemic variable vessel vasculitis that involves the skin, mucosa, joints, eyes, arteries, veins, nervous system and gastrointestinal system, presenting with remissions and exacerbations. It is a multifactorial disease, and several triggering factors including oral cavity infections and viruses may induce inflammatory attacks in genetically susceptible individuals. BD vasculitis involves different vessel types and sizes of the vascular tree with mixed-cellular perivascular infiltrates and is often complicated by recurrent thrombosis, particularly in the venous compartment. Several new therapeutic modalities with different mechanisms of action have been studied in patients with BD. A substantial amount of new data have been published on the management of BD, especially with biologics, over the last years. These important therapeutic advances in BD have led us to propose French recommendations for the management of Behçet's disease [Protocole National de Diagnostic et de Soins de la maladie de Behçet (PNDS)]. These recommendations are divided into two parts: (1) the diagnostic process and initial assessment; (2) the therapeutic management. Thirty key points summarize the essence of the recommendations. We highlighted the main differential diagnosis of BD according to the type of clinical involvement; the role of genetics is also discussed, and we indicate the clinical presentations that must lead to the search for a genetic cause.

Entities:  

Keywords:  Behçet’s disease; Management; Recommendation

Year:  2021        PMID: 33622338      PMCID: PMC7903591          DOI: 10.1186/s13023-020-01620-4

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  62 in total

Review 1.  Behçet's disease.

Authors:  Adriana A Bonfioli; Fernando Orefice
Journal:  Semin Ophthalmol       Date:  2005 Jul-Sep       Impact factor: 1.975

Review 2.  Current concepts in the etiology and treatment of Behçet disease.

Authors:  Cem Evereklioglu
Journal:  Surv Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 6.048

3.  PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists.

Authors:  Luca Cantarini; Antonio Vitale; Giulia Bersani; Laura Martin Nieves; Marco Cattalini; Giuseppe Lopalco; Francesco Caso; Luisa Costa; Florenzo Iannone; Giovanni Lapadula; Mauro Galeazzi; Angela Ceribelli; Enrico Brunetta; Carlo Selmi; Donato Rigante
Journal:  Clin Rheumatol       Date:  2015-02-10       Impact factor: 2.980

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.

Authors:  Bahram Bodaghi; Gael Gendron; Bertrand Wechsler; Céline Terrada; Nathalie Cassoux; Du Le Thi Huong; Claire Lemaitre; Christine Fradeau; Phuc LeHoang; Jean-Charles Piette
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

Review 6.  Ocular Behçet disease: current therapeutic approaches.

Authors:  Cem Evereklioglu
Journal:  Curr Opin Ophthalmol       Date:  2011-11       Impact factor: 3.761

Review 7.  Laser flare-cell photometry: methodology and clinical applications.

Authors:  John G Ladas; Noel C Wheeler; Patrick J Morhun; Steven O Rimmer; Gary N Holland
Journal:  Surv Ophthalmol       Date:  2005 Jan-Feb       Impact factor: 6.048

8.  Cranial MRI in Behçet's disease: 134 examinations of 98 patients.

Authors:  G Akman-Demir; S Bahar; O Coban; B Tasci; P Serdaroglu
Journal:  Neuroradiology       Date:  2003-10-14       Impact factor: 2.804

Review 9.  The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis.

Authors:  Aksel Siva; Sabahattin Saip
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

Review 10.  Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review.

Authors:  Alban Deroux; Chistophe Chiquet; Laurence Bouillet
Journal:  Semin Arthritis Rheum       Date:  2015-12-02       Impact factor: 5.532

View more
  3 in total

Review 1.  Endovascular treatment in Behçet's disease: an integrative review.

Authors:  Lígia Sant'Ana Dumont; Renan Rodrigues de Oliveira Cunha; Thais Carolina Alves Cardoso; Lygia Gomes Fleury; Augusto Wagner Santos Nunes; Pablo Ricardo França Oliveira; Hígor Chagas Cardoso
Journal:  J Vasc Bras       Date:  2022-06-27

2.  [Colchicine: old medication with new benefits : Use in rheumatology and beyond].

Authors:  Z Boyadzhieva; N Ruffer; M Krusche
Journal:  Z Rheumatol       Date:  2021-06-07       Impact factor: 1.372

Review 3.  Old and New Challenges in Uveitis Associated with Behçet's Disease.

Authors:  Julie Gueudry; Mathilde Leclercq; David Saadoun; Bahram Bodaghi
Journal:  J Clin Med       Date:  2021-05-26       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.